BioSpace News Archive

Entos Pharmaceuticals (Entos), a healthcare biotechnology company developing nucleic acid medicines with its breakthrough proprietary Fusogenix drug delivery platform, is pleased to announce it is receiving advisory services and funding of up to $5M from the National Research Council of Canada Industrial Research Assistance Program

Akumin Inc. (NASDAQ: AKU) (TSX: AKU) (the “Issuer”), announced today that it priced a private offering (the “Private Offering”) of $400 million of aggregate principal amount of 7.00% senior secured notes due 2025 (the “Notes”). The offering of the Notes is scheduled to close on November 2, 2020 , s

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”) announces that it has applied for a voluntary management cease trade order in accordance with National Policy 12-203 due to it not being able to file its annual financial statements and MD&A for the year ended June 30, 2020 on SEDAR within 120 days of its financial year-end. The Company requires additional time to file its annual financial statements and MD&a

ATW Tech Inc. (the “Company” or “ATWTech”) (TSX-V: ATW) provides an update on the acquisition of Semeon Analytics Inc. (the “Acquisition”) and the private placement (the “Private Placement”) that were announced on October 1, 2020. ATW Tech has decided to postpone the estimated closing date of the Acquisition and the Private Placement in order to complete the due diligence of Semeon Analytics Inc.

According to Transparency Market Research’s latest report on the global medical imaging equipment services market for the historical period 2017–2018 and forecast period 2019–2027, Hospital centric business model favoring long term partnerships is projected to drive the global medical imaging equipment services market during the forecast period

Hereditary testing is usually referred to as genetic testing or DNA testing. Hereditary testing is employed to spot alterations in the DNA sequence that correlate with a disease or higher risk to develop a disease.

The global foot and mouth disease vaccines market is foreseen to attain growth as vaccination is considered to be a basic yet important initiative undertaken to curb animal loss.

According to Transparency Market Research’s latest report on the global durable medical equipment market for the historical period 2017–2018 and forecast period 2019–2027, increasing number of people with one or more disabilities, rising government initiatives in preventive health care programs are projected to drive the global durable medical equipment market during the forecast period

Mitsubishi Chemical Holdings Corporation announced that, at the meeting of its Board of Directors held , it resolved change of representative corporate executive officers as outlined below.

INTERLINK-1 represents first Phase 3 study examining IO approach in R/M SCCHN patients who have been treatedwith a platinum-based therapy and PD-(L)1 inhibitor